Fas ligand acts as a counter-receptor in Schwann cells and induces the secretion of bioactive nerve growth factor

Journal of Neuroimmunology

Volumn 230, Issue 1-2, 2011, Pages 17-25

  Mimouni Rongy, Manuelle ^a   White, John H ^a   Weinstein, David E ^b   Desbarats, Julie ^a   Almazan, Guillermina ^a  

^a MCGILL UNIVERSITY   (Canada)

^b GliaMed Inc   (United States)

Author keywords

ERK1 2; FasL; NGF; Reverse signalling; Schwann cells; Src kinase

Indexed keywords

FAS LIGAND; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NERVE GROWTH FACTOR; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; BIOLOGICAL ACTIVITY; CELL ACTIVATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; MOUSE; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; SCHWANN CELL; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; FAS LIGAND PROTEIN; HUMANS; MICE; MICE, INBRED C57BL; NERVE GROWTH FACTOR; NEURITES; PC12 CELLS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCHWANN CELLS; SIGNAL TRANSDUCTION;

EID: 78650987217     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.08.010     Document Type: Article

References (61)

1. Adachi M., Watanabe-Fukunaga R., Nagata S. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc. Natl Acad. Sci. USA 1993, 90:1756-1760.
2. Aggarwal B.B. Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 2003, 3:745-756.
3. Anand P., Terenghi G., Birch R., Wellmer A., Cedarbaum J.M., Lindsay R.M., Williams-Chestnut R.E., Sinicropi D.V. Endogenous NGF and CNTF levels in human peripheral nerve injury. NeuroReport 1997, 8:1935-1938.
4. Anton E.S., Weskamp G., Reichardt L.F., Matthew W.D. Nerve growth factor and its low-affinity receptor promote Schwann cell migration. Proc. Natl Acad. Sci. USA 1994, 91:2795-2799.
5. Bampton E.T., Taylor J.S. Effects of Schwann cell secreted factors on PC12 cell neuritogenesis and survival. J. Neurobiol. 2005, 63:29-48.
6. Bonetti B., Valdo P., Ossi G., De Toni L., Masotto B., Marconi S., Rizzuto N., Nardelli E., Moretto G. T-cell cytotoxicity of human Schwann cells: TNFalpha promotes fasL-mediated apoptosis and IFN gamma perforin-mediated lysis. Glia 2003, 43:141-148.
7. Boutry J.M., Hauw J.J., Gansmuller A., Di-Bert N., Pouchelet M., Baron-Van Evercooren A. Establishment and characterization of a mouse Schwann cell line which produces myelin in vivo. J. Neurosci. Res. 1992, 32:15-26.
8. Bunge R.P. The role of the Schwann cell in trophic support and regeneration. J. Neurol. 1994, 242:S19-S21.
9. Choi C., Benveniste E.N. Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses. Brain Res. Brain Res. Rev. 2004, 44:65-81.
10. Desbarats J., Duke R.C., Newell M.K. Newly discovered role for Fas ligand in the cell-cycle arrest of CD4+ T cells. Nat. Med. 1998, 4:1377-1382.
11. Desbarats J., Birge R.B., Mimouni-Rongy M., Weinstein D.E., Palerme J.S., Newell M.K. Fas engagement induces neurite growth through ERK activation and p35 upregulation. Nat. Cell Biol. 2003, 5:118-125.
12. Eissner G., Kolch W., Scheurich P. Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system. Cytokine Growth Factor Rev. 2004, 15:353-366.
13. Fragoso G., Robertson J., Athlan E., Tam E., Almazan G., Mushynski W.E. Inhibition of p38 mitogen-activated protein kinase interferes with cell shape changes and gene expression associated with Schwann cell myelination. Exp. Neurol. 2003, 183:34-46.
14. French L.E., Hahne M., Viard I., Radlgruber G., Zanone R., Becker K., Muller C., Tschopp J. Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J. Cell Biol. 1996, 133:335-343.
15. Friedman W.J., Thakur S., Seidman L., Rabson A.B. Regulation of nerve growth factor mRNA by interleukin-1 in rat hippocampal astrocytes is mediated by NFkappaB. J. Biol. Chem. 1996, 271:31115-31120.
16. Frostick S.P., Yin Q., Kemp G.J. Schwann cells, neurotrophic factors, and peripheral nerve regeneration. Microsurgery 1998, 18:397-405.
17. Ghadimi M.P., Sanzenbacher R., Thiede B., Wenzel J., Jing Q., Plomann M., Borkhardt A., Kabelitz D., Janssen O. Identification of interaction partners of the cytosolic polyproline region of CD95 ligand (CD178). FEBS Lett. 2002, 519:50-58.
18. Greene L.A., Tischler A.S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl Acad. Sci. USA 1976, 73:2424-2428.
19. Hane M., Lowin B., Peitsch M., Becker K., Tschopp J. Interaction of peptides derived from the Fas ligand with the Fyn-SH3 domain. FEBS Lett. 1995, 373:265-268.
20. Hengerer B., Lindholm D., Heumann R., Ruther U., Wagner E.F., Thoenen H. Lesion-induced increase in nerve growth factor mRNA is mediated by c-fos. Proc. Natl Acad. Sci. USA 1990, 87:3899-3903.
21. Heumann R., Korsching S., Bandtlow C., Thoenen H. Changes of nerve growth factor synthesis in nonneuronal cells in response to sciatic nerve transection. J. Cell Biol. 1987, 104:1623-1631.
22. Huang J., Ye Z., Hu X., Lu L., Luo Z. Electrical stimulation induces calcium-dependent release of NGF from cultured Schwann cells. Glia 2010, 58:622-631.
23. Ip N.Y., Stitt T.N., Tapley P., Klein R., Glass D.J., Fandl J., Greene L.A., Barbacid M., Yancopoulos G.D. Similarities and differences in the way neurotrophins interact with the Trk receptors in neuronal and nonneuronal cells. Neuron 1993, 10:137-149.
24. Jessen K.R., Mirsky R. Origin and early development of Schwann cells. Microsc. Res. Tech. 1998, 41:393-402.
25. Jessen K.R., Mirsky R. The origin and development of glial cells in peripheral nerves. Nat. Rev. Neurosci. 2005, 6:671-682.
26. Levi A., Biocca S., Cattaneo A., Calissano P. The mode of action of nerve growth factor in PC12 cells. Mol. Neurobiol. 1988, 2:201-226.
27. Linkermann A., Qian J., Janssen O. Slowly getting a clue on CD95 ligand biology. Biochem. Pharmacol. 2003, 66:1417-1426.
28. Matsuoka I., Meyer M., Thoenen H. Cell-type-specific regulation of nerve growth factor (NGF) synthesis in non-neuronal cells: comparison of Schwann cells with other cell types. J. Neurosci. 1991, 11:3165-3177.
29. Meier C., Parmantier E., Brennan A., Mirsky R., Jessen K.R. Developing Schwann cells acquire the ability to survive without axons by establishing an autocrine circuit involving insulin-like growth factor, neurotrophin-3, and platelet-derived growth factor-BB. J. Neurosci. 1999, 19:3847-3859.
30. Mirsky R., Woodhoo A., Parkinson D.B., Arthur-Farraj P., Bhaskaran A., Jessen K.R. Novel signals controlling embryonic Schwann cell development, myelination and dedifferentiation. J. Peripher. Nerv. Syst. 2008, 13:122-135.
31. Moalem G., Monsonego A., Shani Y., Cohen I.R., Schwartz M. Differential T cell response in central and peripheral nerve injury: connection with immune privilege. FASEB J. 1999, 13:1207-1217.
32. Mowla S.J., Pareek S., Farhadi H.F., Petrecca K., Fawcett J.P., Seidah N.G., Morris S.J., Sossin W.S., Murphy R.A. Differential sorting of nerve growth factor and brain-derived neurotrophic factor in hippocampal neurons. J. Neurosci. 1999, 19:2069-2080.
33. Newell M.K., Desbarats J. Fas ligand: receptor or ligand? Apoptosis 1999, 4:311-315.
34. Pannunzio M.E., Jou I.M., Long A., Wind T.C., Beck G., Balian G. A new method of selecting Schwann cells from adult mouse sciatic nerve. J. Neurosci. Meth. 2005, 149:74-81.
35. Peter M.E., Budd R.C., Desbarats J., Hedrick S.M., Hueber A.O., Newell M.K., Owen L.B., Pope R.M., Tschopp J., Wajant H., Wallach D., Wiltrout R.H., Zornig M., Lynch D.H. The CD95 receptor: apoptosis revisited. Cell 2007, 129:447-450.
36. Reynolds M.L., Woolf C.J. Reciprocal Schwann cell-axon interactions. Curr. Opin. Neurobiol. 1993, 3:683-693.
37. Shaw G., Kamen R. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 1986, 46:659-667.
38. Sofroniew M.V., Howe C.L., Mobley W.C. Nerve growth factor signaling, neuroprotection, and neural repair. Annu. Rev. Neurosci. 2001, 24:1217-1281.
39. Squinto S.P., Stitt T.N., Aldrich T.H., Davis S., Bianco S.M., Radziejewski C., Glass D.J., Masiakowski P., Furth M.E., Valenzuela D.M., et al. trkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor. Cell 1991, 65:885-893.
40. Stoll G., Jander S., Myers R.R. Degeneration and regeneration of the peripheral nervous system: from Augustus Waller's observations to neuroinflammation. J. Peripher. Nerv. Syst. 2002, 7:13-27.
41. Suda T., Takahashi T., Golstein P., Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993, 75:1169-1178.
42. Sun M., Fink P.J. A new class of reverse signaling costimulators belongs to the TNF family. J. Immunol. 2007, 179:4307-4312.
43. Sun M., Ames K.T., Suzuki I., Fink P.J. The cytoplasmic domain of Fas ligand costimulates TCR signals. J. Immunol. 2006, 177:1481-1491.
44. Sun M., Lee S., Karray S., Levi-Strauss M., Ames K.T., Fink P.J. Cutting edge: two distinct motifs within the Fas ligand tail regulate Fas ligand-mediated costimulation. J. Immunol. 2007, 179:5639-5643.
45. Suzuki I., Fink P.J. Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J. Exp. Med. 1998, 187:123-128.
46. Takahashi T., Tanaka M., Inazawa J., Abe T., Suda T., Nagata S. Human Fas ligand: gene structure, chromosomal location and species specificity. Int. Immunol. 1994, 6:1567-1574.
47. Tanaka M., Suda T., Takahashi T., Nagata S. Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J. 1995, 14:1129-1135.
48. Tang B., Wang M., Wise B.C. Nerve growth factor mRNA stability is controlled by a cis-acting instability determinant in the 3′-untranslated region. Brain Res. Mol. Brain Res. 1997, 46:118-126.
49. Terenghi G. Peripheral nerve regeneration and neurotrophic factors. J. Anat. 1999, 194(Pt 1):1-14.
50. Thornhill P.B., Cohn J.B., Drury G., Stanford W.L., Bernstein A., Desbarats J. A proteomic screen reveals novel Fas ligand interacting proteins within nervous system Schwann cells. FEBS Lett. 2007, 581:4455-4462.
51. Trauth B.C., Klas C., Peters A.M., Matzku S., Moller P., Falk W., Debatin K.M., Krammer P.H. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989, 245:301-305.
52. Ulisse S., Cinque B., Silvano G., Rucci N., Biordi L., Cifone M.G., D'Armiento M. Erk-dependent cytosolic phospholipase A2 activity is induced by CD95 ligand cross-linking in the mouse derived Sertoli cell line TM4 and is required to trigger apoptosis in CD95 bearing cells. Cell Death Differ. 2000, 7:916-924.
53. Verderio C., Bianco F., Blanchard M.P., Bergami M., Canossa M., Scarfone E., Matteoli M. Cross talk between vestibular neurons and Schwann cells mediates BDNF release and neuronal regeneration. Brain Cell Biol. 2006, 35:187-201.
54. Voss M., Lettau M., Janssen O. Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening. BMC Immunol. 2009, 10:53.
55. Watabe K., Fukuda T., Tanaka J., Honda H., Toyohara K., Sakai O. Spontaneously immortalized adult mouse Schwann cells secrete autocrine and paracrine growth-promoting activities. J. Neurosci. Res. 1995, 41:279-290.
56. Weinstein D.E., Wu R. Isolation and purification of primary Schwann cells. Curr. Protoc. Neurosci. 2001, Suppl. 8,. Chapter 3, Unit 3.17.1-9.
57. Wenzel J., Sanzenbacher R., Ghadimi M., Lewitzky M., Zhou Q., Kaplan D.R., Kabelitz D., Feller S.M., Janssen O. Multiple interactions of the cytosolic polyproline region of the CD95 ligand: hints for the reverse signal transduction capacity of a death factor. FEBS Lett. 2001, 509:255-262.
58. Wohlleben G., Ibrahim S.M., Schmidt J., Toyka K.V., Hartung H.P., Gold R. Regulation of Fas and FasL expression on rat Schwann cells. Glia 2000, 30:373-381.
59. Wu R., Jurek M., Sundarababu S., Weinstein D.E. The POU gene Brn-5 is induced by neuregulin and is restricted to myelinating Schwann cells. Mol. Cell. Neurosci. 2001, 17:683-695.
60. Yonehara S., Ishii A., Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 1989, 169:1747-1756.
61. Zhong W., Zaheer A., Lim R. Ciliary neurotrophic factor (CNTF) enhances the effects of nerve growth factor on PC12 cells. Brain Res. 1994, 661:56-62.